HAT SGR is the only italian investor in Huma Therapeutics

HAT SGR, a Private Equity firm led by Ignazio Castiglioni and chaired by Nino Attanasio, participated – as the only Italian investment fund – in the $80 million capital increase of Huma Therapeutics, an artificial intelligence company in the healthcare sector. The new resources will be used for the launch of Huma Cloud Platform, the company’s new digital platform with GenAI integrations, which combines predictive algorithms, digital biomarkers, and real-world data to advance care and research in a digital mode.